Tag - diovan

 
Menu
Search
 
April 20, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

DIOVAN

Japan Times
JAPAN / Science & Health / A MATTER OF HEALTH
Nov 15, 2017
Japanese doctor who exposed a drug too good to be true calls for morality and reforms
It was a gut feeling and common sense that made Dr. Iwao Kuwajima question a drug for high blood pressure that just about every other doctor in his field was excited about in the 2000s.
JAPAN / Crime & Legal
Jul 1, 2014
Novartis Pharma, ex-employee charged over drug data manipulation
Tokyo prosecutors charged Novartis Pharma K.K. and a former employee Tuesday with causing a medical research team to release data manipulated in favor of the firm's drug for treating high blood pressure in 2011.
JAPAN / Crime & Legal
Jun 11, 2014
Ex-Novartis worker seized for faking clinical trial data of blood pressure drug
A former employee of Novartis Pharma K.K. has been arrested for allegedly manipulating clinical study data for one of the company's drugs.
Japan Times
JAPAN
Feb 27, 2014
Diovan scandal traced to cozy doctor-drugmaker ties
The manipulation of clinical research data used to develop the blood pressure drug Diovan sold by Novartis Pharma K.K. has prompted a special squad of Tokyo prosecutors to search the Japanese unit of the Swiss drugmaker as well as the universities that conducted the research.
JAPAN
Feb 19, 2014
Tokyo prosecutors raid Novartis Pharma over drug ads
Tokyo prosecutors raided Novartis Pharma K.K. on Wednesday over its alleged use of exaggerated advertising for a blood pressure-lowering drug, following a criminal complaint filed by the health ministry last month.
EDITORIALS
Jan 14, 2014
Lessons from the Diovan scandal
Fallout from the Diovan case in Japan suggests that clinical drug studies on patients should be financed either with public research funds or through formal funding contracts between pharmaceutical companies and the research institutions involved — rather than by pharma donations.
Japan Times
JAPAN / EXPLAINER
Jan 13, 2014
Novartis drug's data-tampering reflects unchecked collusion
Last week, the Health, Labor and Welfare Ministry filed a criminal complaint with prosecutors against Novartis Pharma K.K., the Japanese subsidiary of Swiss pharmaceutical giant Novartis, alleging the firm made exaggerated advertising claims for its blockbuster blood pressure drug Diovan.
JAPAN / Crime & Legal
Jan 8, 2014
Ministry targets Novartis claims for legal action
The health ministry is making final arrangements to file a criminal complaint with prosecutors against Novartis Pharma K.K. over alleged exaggerated advertising for a blood pressure-lowering drug in violation of the pharmaceutical affairs law, ministry officials said Wednesday.
JAPAN / Crime & Legal
Dec 18, 2013
Novartis false ad complaint planned
The health ministry is planning to file a criminal complaint against Novartis Pharma K.K. over alleged use of false advertising for its Diovan blood pressure-lowering drug, officials said Wednesday.
Japan Times
JAPAN
Oct 31, 2013
Another study report on Novartis drug found inappropriate
Shiga University of Medical Science on Thursday became the third Japanese institution to conclude that a clinical study report on Novartis Pharma K.K.'s Diovan blood pressure-lowering drug contained doubtful data and was inappropriate.
EDITORIALS
Oct 19, 2013
Remedies for rigged research
It still isn't clear who manipulated clinical research data in favor of Novartis Pharma's blood-pressure drug Diovan, casting a cloud on the credibility of Japan's medical universities.
JAPAN / Science & Health
Aug 7, 2013
Novartis ordered to state skin disorders as Diovan side effects
The health ministry has instructed Novartis Pharma K.K. to state in an attached note for its Diovan blood pressure-lowering drug that the medicine may cause serious skin disorders.
JAPAN
Jul 31, 2013
Another Japanese university finds data manipulation for Novartis drug
The Jikei University School of Medicine has become the second Japanese university to find that clinical data had been manipulated for a Novartis Pharma drug that lowers blood pressure.
JAPAN
Jul 29, 2013
Health ministry probes Diovan skin disruption reports
The health ministry is investigating reports of skin problems linked to the use of Diovan, Novartis Pharma K.K.'s popular drug for reducing high blood pressure, sources familiar with the matter said Monday.
EDITORIALS
Jul 28, 2013
Question of objectivity
A Kyoto university's announcement that research on blood-pressure drug Diovan was manipulated raises concerns about the drugmaker's objectivity.
No link to Nankai Trough quake seen after temblor in Shikoku
Satoshi Harada from the Meteorological Agency explains about the magnitude 6.6 earthquake during a news conference early Thursday.
Tehran signals no retaliation against Israel after drones attack Iran
A reported strike against Iran by Israel on Friday came against the backdrop of Iran's support for the Palestinian Hamas militant group, whose assault into Israel on Oct. 7 triggered Israel's invasion of Gaza.
In a first, Japan doctors sue Google over negative reviews on firm's map app
One of the lawyers representing a group of doctors suing Google told a news conference that the main purpose of the lawsuit is not to seek compensation but instead to raise awareness over various problems with the Google Maps system.
Former No. 1 Kento Momota retires from international badminton at 29
Badminton star Kento Momota leaves a news conference after announcing his retirement from Japan's national team, in Tokyo on Thursday.
Thousands evacuated as Indonesia volcano erupts
Indonesia's Mount Ruang spews hot lava and smoke as seen from Sitaro, North Sulawesi, on Wednesday.
'House of the Owl' brings Hollywood values to Japanese TV
In the new Disney+ series “House of the Owl,” Min Tanaka (left) plays a powerful political fixer, or “kuromaku,” who has a troubled relationship with his adult children, particularly his idealistic son, played by Mackenyu.
Benefits and risks: AUKUS looks to take gamble on Japan
U.S. President Joe Biden, Australian Prime Minister Anthony Albanese and British leader Rishi Sunak deliver remarks on the AUKUS partnership, after a trilateral meeting, at Naval Base Point Loma in San Diego in March last year.
Kyoto’s demon night parade lives to haunt another day
In a Kyoto long past, the "hyakki yagyō" (100 demon night parade) haunted a sleepy corner of Kyoto. Now, one enterprising monster enthusiast has won a small batttle to keep the march alive.
U.S. deploys midrange missile system in Indo-Pacific for first time
A U.S. Army Mid-Range Capability (MRC) Launcher arrives as part of the capability’s first deployment into theater on Northern Luzon, Philippines, April 8.
Unpacking the chaotic by-election in a scandal-hit Tokyo district
People listen to a campaign speech in Tokyo's Koto Ward on Tuesday.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Historically, kabuki was considered the entertainment of the merchant and peasant classes, a far cry from how it is regarded today.
For Japan's oldest kabuki theater, the show must go on
By Lance Henderstein

SUSTAINABLE JAPAN

Prize winner Maki Imoto catches light with glass
Prize winner Maki Imoto catches light with glass

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER